Lipocine Inc (LPCN)
4.80
-0.27
(-5.33%)
USD |
NASDAQ |
Apr 23, 16:00
4.72
-0.08
(-1.67%)
After-Hours: 20:00
Lipocine Shareholders Equity (Quarterly): 20.37M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 20.37M |
| September 30, 2023 | 22.48M |
| June 30, 2023 | 28.55M |
| March 31, 2023 | 31.96M |
| December 31, 2022 | 35.63M |
| September 30, 2022 | 37.65M |
| June 30, 2022 | 39.89M |
| March 31, 2022 | 42.41M |
| December 31, 2021 | 45.57M |
| September 30, 2021 | 32.81M |
| June 30, 2021 | 35.75M |
| March 31, 2021 | 42.39M |
| December 31, 2020 | 15.34M |
| September 30, 2020 | 14.51M |
| June 30, 2020 | 13.08M |
| March 31, 2020 | 6.553M |
| December 31, 2019 | 6.288M |
| September 30, 2019 | 7.505M |
| June 30, 2019 | 9.850M |
| March 31, 2019 | 12.55M |
| December 31, 2018 | 9.434M |
| September 30, 2018 | 11.76M |
| June 30, 2018 | 13.88M |
| March 31, 2018 | 16.67M |
| Date | Value |
|---|---|
| December 31, 2017 | 18.98M |
| September 30, 2017 | 23.77M |
| June 30, 2017 | 25.15M |
| March 31, 2017 | 24.88M |
| December 31, 2016 | 26.02M |
| September 30, 2016 | 27.98M |
| June 30, 2016 | 30.76M |
| March 31, 2016 | 35.78M |
| December 31, 2015 | 41.99M |
| September 30, 2015 | 46.25M |
| June 30, 2015 | 52.13M |
| March 31, 2015 | 23.72M |
| December 31, 2014 | 26.36M |
| September 30, 2014 | 29.96M |
| June 30, 2014 | 33.82M |
| March 31, 2014 | 40.60M |
| December 31, 2013 | 44.82M |
| September 30, 2013 | 35.54M |
| June 30, 2013 | -0.0176M |
| March 31, 2013 | -0.0145M |
| December 31, 2012 | -0.0113M |
| September 30, 2012 | -0.0064M |
| June 30, 2012 | -0.0007M |
| March 31, 2012 | 0.02M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.288M
Minimum
Dec 2019
45.57M
Maximum
Dec 2021
25.72M
Average
28.55M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Alpine Immune Sciences Inc | 327.94M |
| Eliem Therapeutics Inc | 107.60M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -11.38M |
| iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 23.00M |
| Total Liabilities (Quarterly) | 2.632M |
| Current Ratio | 8.687 |